Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom (Q74587622)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 1998

Language	Label	Description	Also known as
English	Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom	scientific article published on 01 April 1998

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease promoting mechanisms (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

experimental autoimmune encephalomyelitis

1 reference

based on heuristic

inferred from title

author name string

P H van der Meide

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M C de Labie

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S R Ruuls

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R J Groenestein

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C A Botman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

T Olsson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C D Dijkstra

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 April 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Journal of Neuroimmunology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

84

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

14-23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Suppression of experimental allergic encephalomyelitis by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon in experimental autoimmune encephalomyelitis (EAE): effects of exogeneous interferon on the antigen-enhanced adoptive transfer of EAE

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis and immunotherapy of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-beta impairs induction of HLA-DR antigen expression in cultured adult human astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of lymphocyte mitogenesis by (2′–5′) oligo-isoadenylate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphocyte migration into brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell immunity and interferon-γ secretion during experimental allergic encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuronal interferon-gamma immunoreactive molecule: bioactivities and purification

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical viral infections and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-beta downregulates expression of VLA-4 antigen and antagonizes interferon-gamma-induced expression of HLA-DQ on human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mercuric chloride down-regulates T cell interferon-gamma production in brown Norway but not in Lewis rats; role of glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the inhibitory effect of immunosuppressive agents on rat T cell interferon-gamma production using an ELISPOT assay

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The interferons: biological effects, mechanisms of action, and use in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900207-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0165-5728(97)00207-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600704%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74587622&oldid=1755970291"